Jaguar Animal Health SG&A Expenses 2014-2025 | JAGX

Jaguar Animal Health sg&a expenses from 2014 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Jaguar Animal Health Annual SG&A Expenses
(Millions of US $)
2024 $24
2023 $23
2022 $27
2021 $26
2020 $21
2019 $20
2018 $22
2017 $14
2016 $6
2015 $6
2014 $4
2013 $0
Jaguar Animal Health Quarterly SG&A Expenses
(Millions of US $)
2025-03-31 $7
2024-12-31 $7
2024-09-30 $6
2024-06-30 $6
2024-03-31 $6
2023-12-31 $5
2023-09-30 $5
2023-06-30 $6
2023-03-31 $7
2022-12-31 $5
2022-09-30 $6
2022-06-30 $6
2022-03-31 $9
2021-12-31 $7
2021-09-30 $6
2021-06-30 $7
2021-03-31 $6
2020-12-31 $5
2020-09-30 $6
2020-06-30 $5
2020-03-31 $5
2019-12-31 $5
2019-09-30 $5
2019-06-30 $5
2019-03-31 $5
2018-12-31 $6
2018-09-30 $5
2018-06-30 $6
2018-03-31 $5
2017-12-31 $5
2017-09-30 $4
2017-06-30 $2
2017-03-31 $3
2016-12-31 $2
2016-09-30 $1
2016-06-30 $1
2016-03-31 $2
2015-12-31 $2
2015-09-30 $2
2015-06-30 $1
2015-03-31 $1
2014-12-31 $1
2014-09-30 $1
2014-06-30 $1
2014-03-31 $0
2013-12-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.003B $0.012B
Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $86.719B 32.53
Zoetis (ZTS) US $69.528B 25.94
Takeda Pharmaceutical (TAK) JP $48.047B 9.56
Daiichi Sankyo, - (DSNKY) JP $43.343B 22.21
BeOne Medicines - (ONC) KY $26.436B 0.00
Sandoz Group AG (SDZNY) CH $23.802B 0.00
Merck (MKKGY) DE $17.015B 12.47
Summit Therapeutics (SMMT) US $15.299B 0.00
Shionogi (SGIOY) JP $14.887B 14.91
United Therapeutics (UTHR) US $12.823B 11.34
Neurocrine Biosciences (NBIX) US $12.412B 42.52
Orion OYJ (ORINY) FI $10.495B 28.38
IPSEN (IPSEY) FR $9.739B 0.00
Corcept Therapeutics (CORT) US $7.765B 63.12
Stevanato Group S.p.A (STVN) IT $7.462B 45.63
Madrigal Pharmaceuticals (MDGL) US $6.678B 0.00
Ionis Pharmaceuticals (IONS) US $6.335B 0.00
Hikma Pharmaceuticals Plc (HKMPF) GB $6.153B 0.00
Grifols, S.A (GRFS) ES $6.092B 0.00
Ono Pharmaceutical (OPHLF) JP $4.382B 13.33
Soleno Therapeutics (SLNO) US $4.195B 0.00
Hypermarcas (HYPMY) BR $3.072B 20.21
Crinetics Pharmaceuticals (CRNX) US $2.805B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.657B 9.31
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.548B 13.78
NewAmsterdam Pharma (NAMS) NL $2.085B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.959B 0.00
ARS Pharmaceuticals (SPRY) US $1.787B 0.00
Centessa Pharmaceuticals (CNTA) GB $1.754B 0.00
Endo (NDOI) US $1.603B 0.00
Evotec AG (EVO) DE $1.477B 0.00
Ocular Therapeutix (OCUL) US $1.469B 0.00
Guardian Pharmacy Services (GRDN) US $1.353B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.167B 23.35
Harrow (HROW) US $1.133B 0.00
Dyne Therapeutics (DYN) US $1.088B 0.00
Enliven Therapeutics (ELVN) US $1.015B 0.00
Verve Therapeutics (VERV) US $1.007B 0.00
Collegium Pharmaceutical (COLL) US $0.962B 5.19
Akebia Therapeutics (AKBA) US $0.959B 0.00
Avadel Pharmaceuticals (AVDL) IE $0.890B 0.00
Ardelyx (ARDX) US $0.883B 0.00
Elite Pharmaceuticals (ELTP) US $0.760B 0.00
Xeris Biopharma Holdings (XERS) US $0.735B 0.00
Cronos Group (CRON) CA $0.733B 0.00
USANA Health Sciences (USNA) US $0.580B 12.60
Xencor (XNCR) US $0.579B 0.00
KalVista Pharmaceuticals (KALV) US $0.567B 0.00
Relay Therapeutics (RLAY) US $0.566B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.564B 0.00
Theravance Biopharma (TBPH) US $0.561B 0.00
Bioventus (BVS) US $0.556B 14.10
Zevra Therapeutics (ZVRA) US $0.492B 0.00
AleAnna (ANNA) US $0.481B 0.00
Organogenesis (ORGO) US $0.466B 0.00
Siga Technologies (SIGA) US $0.462B 9.64
Tourmaline Bio (TRML) US $0.425B 0.00
Oruka Therapeutics (ORKA) US $0.415B 0.00
Savara (SVRA) US $0.382B 0.00
Rigel Pharmaceuticals (RIGL) US $0.348B 9.41
Heron Therapeutics (HRTX) US $0.326B 0.00
Aquestive Therapeutics (AQST) US $0.323B 0.00
Nektar Therapeutics (NKTR) US $0.320B 0.00
Altimmune (ALT) US $0.284B 0.00
Nature's Sunshine Products (NATR) US $0.268B 24.58
Tonix Pharmaceuticals Holding (TNXP) US $0.257B 0.00
Liminatus Pharma (LIMN) US $0.247B 0.00
Aldeyra Therapeutics (ALDX) US $0.227B 0.00
Nanobiotix S.A (NBTX) FR $0.213B 0.00
MediWound (MDWD) IL $0.208B 0.00
OmniAb (OABI) US $0.208B 0.00
Esperion Therapeutics (ESPR) US $0.197B 0.00
ProKidney (PROK) US $0.196B 0.00
Larimar Therapeutics (LRMR) US $0.194B 0.00
Profound Medical (PROF) CA $0.180B 0.00
4D Molecular Therapeutics (FDMT) US $0.178B 0.00
Journey Medical (DERM) US $0.166B 0.00
Innate Pharma SA (IPHYF) FR $0.163B 0.00
Aclaris Therapeutics (ACRS) US $0.159B 0.00
Galectin Therapeutics (GALT) US $0.147B 0.00
Avita Medical (RCEL) US $0.144B 0.00
Lexeo Therapeutics (LXEO) US $0.137B 0.00
Lyell Immunopharma (LYEL) US $0.132B 0.00
Inhibikase Therapeutics (IKT) US $0.120B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.118B 0.00
Cardiol Therapeutics (CRDL) CA $0.117B 0.00
Korro Bio (KRRO) US $0.113B 0.00
VAXART, INC (VXRT) US $0.113B 0.00
Protara Therapeutics (TARA) US $0.111B 0.00
Champions Oncology (CSBR) US $0.107B 17.64
Corbus Pharmaceuticals Holdings (CRBP) US $0.091B 0.00
Arch Biopartners (ACHFF) CA $0.090B 0.00
Nutriband (NTRB) US $0.089B 0.00
Unicycive Therapeutics (UNCY) US $0.086B 0.00
Cassava Sciences (SAVA) US $0.085B 0.00
Dominari Holdings (DOMH) US $0.081B 0.00
Fractyl Health (GUTS) US $0.080B 0.00
Vivani Medical (VANI) US $0.078B 0.00
Achieve Life Sciences (ACHV) CA $0.077B 0.00
Surrozen (SRZN) US $0.077B 0.00
ESSA Pharma (EPIX) CA $0.077B 0.00
Wellgistics Health (WGRX) US $0.073B 0.00
Pyxis Oncology (PYXS) US $0.068B 0.00
Assertio Holdings (ASRT) US $0.062B 0.00
Context Therapeutics (CNTX) US $0.059B 0.00
NRx Pharmaceuticals (NRXP) US $0.059B 0.00
Gain Therapeutics (GANX) US $0.059B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Inotiv (NOTV) US $0.058B 0.00
Rafael Holdings (RFL) US $0.058B 0.00
PMV Pharmaceuticals (PMVP) US $0.056B 0.00
Metagenomi (MGX) US $0.055B 0.00
Avalo Therapeutics (AVTX) US $0.052B 0.00
Verrica Pharmaceuticals (VRCA) US $0.048B 0.00
Telomir Pharmaceuticals (TELO) US $0.046B 0.00
Century Therapeutics (IPSC) US $0.045B 0.00
Prelude Therapeutics (PRLD) US $0.044B 0.00
Mural Oncology (MURA) IE $0.043B 0.00
ElectroCore (ECOR) US $0.040B 0.00
Iterum Therapeutics (ITRM) IE $0.040B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.039B 28.89
Karyopharm Therapeutics (KPTI) US $0.038B 0.00
Acrivon Therapeutics (ACRV) US $0.038B 0.00
PolyPid (PYPD) IL $0.036B 0.00
Jupiter Neurosciences (JUNS) US $0.035B 0.00
Enlivex Therapeutics (ENLV) IL $0.028B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.027B 0.00
SCYNEXIS (SCYX) US $0.027B 0.00
Tempest Therapeutics (TPST) US $0.025B 0.00
Klotho Neurosciences (KLTO) US $0.023B 0.00
VYNE Therapeutics (VYNE) US $0.022B 0.00
FibroGen (FGEN) US $0.021B 0.00
Relmada Therapeutics (RLMD) US $0.020B 0.00
Natural Alternatives (NAII) US $0.020B 0.00
DURECT (DRRX) US $0.019B 0.00
Vivos Therapeutics (VVOS) US $0.019B 0.00
BioLineRx (BLRX) IL $0.019B 0.00
BioVie (BIVI) US $0.019B 0.00
Lipocine (LPCN) US $0.018B 0.00
Mannatech (MTEX) US $0.017B 0.00
Carisma Therapeutics (CARM) US $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.017B 0.00
Citius Pharmaceuticals (CTXR) US $0.016B 0.00
Plus Therapeutics (PSTV) US $0.016B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.016B 0.00
ProPhase Labs (PRPH) US $0.015B 0.00
CASI Pharmaceuticals (CASI) CN $0.015B 0.00
Ernexa Therapeutics (ERNA) US $0.014B 0.00
TherapeuticsMD (TXMD) US $0.013B 0.00
Minerva Neurosciences (NERV) US $0.012B 2.17
Cosmos Health (COSM) US $0.012B 0.00
Scienture Holdings (SCNX) US $0.012B 0.00
Lyra Therapeutics (LYRA) US $0.012B 0.00
Phio Pharmaceuticals (PHIO) US $0.010B 0.00
Ainos (AIMD) US $0.010B 0.00
Crescent Biopharma (CBIO) US $0.010B 0.00
NLS Pharmaceutics (NLSP) CH $0.010B 0.00
Talphera (TLPH) US $0.010B 0.00
Addex Therapeutics (ADXN) CH $0.010B 0.00
Mangoceuticals (MGRX) US $0.009B 0.00
Kiora Pharmaceuticals (KPRX) US $0.009B 0.00
Alaunos Therapeutics (TCRT) US $0.008B 0.00
Biomerica (BMRA) US $0.008B 0.00
Traws Pharma (TRAW) US $0.008B 0.00
Nuvilex (PMCB) US $0.007B 0.00
Indaptus Therapeutics (INDP) US $0.007B 0.00
TransCode Therapeutics (RNAZ) US $0.007B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.006B 0.00
Incannex Healthcare (IXHL) AU $0.006B 0.00
Quoin Pharmaceuticals (QNRX) US $0.005B 0.00
Xenetic Biosciences (XBIO) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.005B 0.00
SHINECO (SISI) CN $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
InMed Pharmaceuticals (INM) CA $0.004B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
CERo Therapeutics Holdings (CERO) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
SciSparc (SPRC) IL $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.003B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.003B 0.00
PainReform (PRFX) IL $0.003B 0.00
Aditxt (ADTX) US $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Heatwurx (PCSA) US $0.002B 0.00
Conduit Pharmaceuticals (CDT) US $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Indivior (INDV) US $0.000B 8.16
4D Pharma (LBPS) GB $0.000B 0.00
MEI Pharma (MEIP) US $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00